Skip to Content


Generic Name: benzoyl peroxide and sulfur
Dosage Form: gel

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

BPS Gel™
6% Benzoyl Peroxide
3% Sulfur

Rx Only


BPS Gel™ is a topical preparation containing benzoyl peroxide 6% and sulfur 3%. The structural formula of benzoyl peroxide is as follows:

INACTIVE INGREDIENTS: Allantoin, Benzyl Alcohol NF, Carbomer 940 NF, Citric Acid (Anhydrous) USP, Colloidal Oatmeal, Disodium Oleamido MEA Sulfosuccinate, Edetate Disodium USP, Glycerin USP, Purified Water USP, Sodium Citrate USP.

BPS Gel - Clinical Pharmacology

The exact mode of action of benzoyl peroxide and sulfur in acne vulgaris is unknown but its antibacterial activity against Propionibacterium acnes is thought to be a major mode of action. Benzoyl peroxide and sulfur are believed to exert a beneficial effect because of their antimicrobial activity and their mild keratolytic action.


BPS Gel™ is indicated in the treatment of acne vulgaris. See Directions section below for information on frequency and duration of medication use.


BPS Gel™ is contraindicated in persons who have shown hypersensitivity to benzoyl peroxide, sulfur, or to any of the other ingredients in the product.

FOR EXTERNAL USE ONLY. Keep out of reach of children. Keep away from eyes. Keep tube tightly closed.


External Use Only. Not for ophthalmic Use. Avoid prolonged sun exposure, tanning booths, and sunlamps.


BPS Gel™ is for external use only. Do not come in contact with eyes or mucous membranes (e.g., inside of nose) and any damaged areas of the skin, such as wounds or open sores. If accidental contact with one of these areas occurs, rinse thoroughly with water. If severe irritation develops, discontinue use and institute appropriate therapy. After reaction clears, treatment may be resumed with less frequent application. Avoid contact with hair, fabrics or carpeting as benzoyl peroxide will cause bleaching.

Carcinogenesis, Mutagenesis, and Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential.


Category C

Animal reproduction studies have not been conducted with BPS Gel™. It is also not known whether BPS Gel™ can cause fetal harm when administered to a pregnant woman. This product should be used only if the potential benefit justifies the potential risk to the fetus.

Nursing Mothers

It is not known whether these drugs are excreted in human milk following topical use of BPS Gel™. However, because many drugs are excreted in human milk, caution should be exercised when administering this medication to a nursing woman.

Pediatric Use

Safety and effectiveness in children under 12 years of age has not been established.

Adverse Reactions

Contact sensitization reactions are associated with the use of topical benzoyl peroxide and sulfur products, and may be expected to occur in 10 to 25 out of 1,000 patients. The most frequent adverse reaction associated with benzoyl peroxide and sulfur use are excessive erythema (redness) and peeling which may be expected to occur in 5 out of every 100 patients. Excessive erythema (redness) and peeling most frequently appear during the initial phase of medication use and may normally be controlled by reducing frequency of use.


Cleanse affected areas. Apply the medication to the affected areas once a day during the first week, and twice a day thereafter as tolerated. Frequency of use should be adjusted to obtain the desired clinical response.

How is BPS Gel Supplied

BPS Gel™ (benzoyl peroxide 6% and sulfur 3%) is supplied in 43 g. tubes. NDC 51991-634-83.


Store at 25° C (77° F); excursions permitted to 15°-30° C (59°-86° F). See USP Controlled Room Temperature. Protect from freezing.

Dispense in original container.

WARNING: Keep this and all medications out of the reach of children. In case of accidental overdose, seek professional assistance or contact a poison control center immediately.

All prescription substitutions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product.

Manufactured by: Groupe Parima Inc., Montréal, QC Canada H4S 1X6

Distributed by: Breckenridge Pharmaceutical, Inc., Boca Raton, FL 33487

Iss: 1/09


Pharmaceutical, Inc.

NDC 51991-634-83

BPS Gel™
6% Benzoyl Peroxide
3% Sulfur

Rx Only
Net Wt. 43 g

Acne Treatment Gel

benzoyl peroxide and sulfur gel
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:51991-634
Route of Administration TOPICAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Benzoyl Peroxide (Benzoyl Peroxide) Benzoyl Peroxide 0.06 g  in 1 g
Sulfur (Sulfur) Sulfur 0.03 g  in 1 g
Inactive Ingredients
Ingredient Name Strength
Benzyl Alcohol  
Carbomer Homopolymer Type C  
Anhydrous Citric Acid  
Disodium Oleamido MEA-Sulfosuccinate  
Edetate Disodium  
Sodium Citrate  
Product Characteristics
Color WHITE Score     
Shape Size
Flavor Imprint Code
# Item Code Package Description
1 NDC:51991-634-83 1 TUBE (TUBE) in 1 BOX
1 43 g in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 11/01/2009 04/30/2011
Labeler - Breckenridge Pharmaceutical, Inc. (150554335)
Name Address ID/FEI Operations
Groupe Parima 252437850 MANUFACTURE
Revised: 12/2010
Breckenridge Pharmaceutical, Inc.